Literature DB >> 33569722

LncPVT1 promotes cartilage degradation in diabetic OA mice by downregulating miR-146a and activating TGF-β/SMAD4 signaling.

Yan-Zhi Wang1, Sheng-Kai Liang1, Luo-Bin Ding1, Jian Guan2, Hua-Jun Wang3.   

Abstract

INTRODUCTION: To investigate the role of LncRNA PVT1 (plasmacytoma variant translocation 1) in hyperglycemia-triggered cartilage damage using the diabetic osteoarthritis (OA) mice model.
MATERIALS AND METHODS: Streptozotocin (STZ) was used to induce mouse diabetes. Knee OA model was induced through transection of anterior cruciate ligament (ACLT). Severity of arthritis was assessed histologically by Safranin O-Fast Green Staining using Mankin Scores. LncRNA PVT1 and miR-146a were detected by real-time polymerase chain reaction (PCR) in cartilage tissue. Moreover, the interaction among PVT1, miR-146a, and SMAD4 was examined by luciferase reporter assays. Mice were injected intra-articularly with ad-siRNA-PVT1 and ad-siRNA scramble control. Articular concentrations of TNF-α, IL-1, IL-6 and TGF-β1 were determined using enzyme-linked immunosorbent assay. Levels of type II Collagen (COL2A1), TGF-β1, p-SMAD2, SMAD2, p-SMAD3, SMAD3, SMAD4 and nuclear SMAD4 were detected by western blot analysis.
RESULTS: PVT1 expression was significantly increased, whereas miR-146a was markedly decreased in diabetic OA mice than in non-diabetic OA and control. Increased PVT1 expression in diabetic OA mice was significantly associated with Mankin score and reduced miR-146a as well as Collagen alpha-1(II) (COL2A1) expressions. In vivo, intra-articular injection of ad-siRNA-PVT1 efficiently increased miR-146a and COL2A1 expressions, alleviated joint inflammation, decreased the expression of pro-inflammatory mediators, and suppressed TGF-β/SMAD4 pathway in diabetic OA mice.
CONCLUSIONS: Our results demonstrate LncRNA PVT1 is involved in cartilage degradation in diabetic OA and correlated with disease severity. Efficiency of ad-siRNA-PVT1 in controlling joint inflammation in diabetic OA mice is associated with the suppression of the expression of miR-146a, pro-inflammatory cytokines and activation of TGF-β/SMAD4 pathway.

Entities:  

Keywords:  Diabetic osteoarthritis; MiR-146; PVT1; TGF-β/SMAD signaling

Year:  2021        PMID: 33569722     DOI: 10.1007/s00774-020-01199-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  3 in total

1.  LncRNA TUG1 promotes osteoarthritis-induced degradation of chondrocyte extracellular matrix via miR-195/MMP-13 axis.

Authors:  L-P Tang; J-B Ding; Z-H Liu; G-J Zhou
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-12       Impact factor: 3.507

2.  LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.

Authors:  Y-J Zhu; D-M Jiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-10       Impact factor: 3.507

3.  The diabetic knee.

Authors:  Sanjay Kalra; Deep Dutta
Journal:  J Pak Med Assoc       Date:  2019-10       Impact factor: 0.781

  3 in total
  4 in total

Review 1.  Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications.

Authors:  Xiaolin Lu; Qihong Tan; Jianyong Ma; Jing Zhang; Peng Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-12

2.  MiR-19b-3p Attenuates Chondrocytes Injury by Inhibiting MAPK/NF-Κb Axis via Targeting SOCS1.

Authors:  Liang Shi; Liang Duan; Dapeng Duan; Yayi Fan; Honghai Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

3.  Long Non-Coding RNA PVT1 and Its Target miRNA-146a as Potential Prognostic Biomarkers in Rheumatoid Arthritis Patients.

Authors:  Randa Erfan; Olfat G Shaker; Mahmoud A F Khalil; Yumn A Elsabagh; Azza M Ahmed; Abeer K Abu-El-Azayem; Mohamed S Gomaa; Asmaa Mohammed
Journal:  Life (Basel)       Date:  2021-12-10

4.  Long non-coding RNA HOTAIRincreased mechanical stimulation-induced apoptosis by regulating microRNA-221/BBC3 axis in C28/I2 cells.

Authors:  Tiansheng Zheng; Jishang Huang; Jinliang Lai; Qingluo Zhou; Tong Liu; Qiang Xu; Guanglin Ji; Yongjun Ye
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.